Quercetin exerts anti-tumor immune mechanism by regulating IL-6/JAK2/STAT3 signaling pathway to deplete Treg cells

Breast Cancer is still the leading cause of death among women worldwide. Due to the lack of effective drug targets, triple-negative breast Cancer has a worse prognosis and higher mortality compared with Other types of breast Cancer, and chemotherapy is still the main treatment for triple-negative breast Cancer at present. Quercetin (QUE) is a flavonoid compound found in a variety of fruits and vegetables. The mechanism of QUE has been extensively studied, such as prostate Cancer, colon Cancer, ovarian Cancer, etc. However, the anti-tumor immune mechanism of QUE in triple-negative breast Cancer remains unclear. Therefore, we assessed the anti-tumor immune effects of QUE on triple-negative breast Cancer using both 4T1 cells and a xenograft mouse model of 4T1 cells. In vitro, we examined the inhibitory effects of QUE on 4T1 cells and its molecular mechanisms through MTT, Transwell, ELISA, and Western blotting. In vivo, by establishing a xenograft mouse model, we utilized flow cytometry, immunohistochemistry, ELISA, and Western blotting to evaluate the anti-tumor immune effects of QUE on triple-negative breast Cancer. The results indicate that QUE inhibits the proliferation, migration, and invasion of 4T1 cells, concurrently significantly suppressing the IL-6/JAK2/STAT3 signaling pathway. Furthermore, it depletes Treg cell content in 4T1 xenograft mice, thereby improving the tumor immune microenvironment and promoting the cytotoxicity of relevant tumor immune cells. These findings suggest that QUE may serve as a potential Adjuvant for immune therapy in triple-negative breast Cancer.

Anti-tumor immune; Breast cancer; IL-6/JAK2/STAT3; Quercetin; Treg.